Arbovax's Angel Round

Arbovax raised a round of funding on January 01, 2014. Investors include Wilmington Investor Network.

Arbovax has a unique technology that modifies arthropod-borne viruses (arboviruses) making them unable to replicate in mammalian cells. Arbovax will leverage this technology through partnerships with …

Articles about Arbovax's Angel Round: